ArticlePDF Available

Effect of Platelet Rich Plasma (PRP) Injection on the Endocrine Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study

Authors:

Abstract and Figures

Introduction: Diabetes mellitus is a global problem and several restoration approaches have been developed to induce beta (β) cells regeneration. Platelet rich plasma (PRP) is an autogenous and economical source of growth factors which nowadays used in the tissue repair. Aim: To test the hypothesis that PRP could play a role in the improvement of the structural changes occurred in the endocrine pancreas of experimentally- induced diabetic rats and the possible mechanisms through which PRP induced its effects to shed a light on the possible use of such application in the clinical field.Material and methods: Sixty male albino rats were used; 20 for obtaining the PRP and 40 were divided into 4 equal groups (10 rats each): control, PRP-group, diabetic group, PRP/diabetic group. Diabetes was induced by single intra-peritoneal injection of streptozotocin (50-60 mg/kg). The PRP was administered by SC injections in a dose of 0.5 mg/kg twice weekly for 3 weeks. Results: The diabetic group showed a significant increase in blood glucose levels compared to the control. Treatment with PRP significantly reduced the blood glucose levels compared to the diabetic group. The diabetic group showed variable marked morphological changes which diminished by the PRP administration. PRP/diabetic group had a significant increase in the mean number of pancreatic islets and β-cells/islet compared to the diabetic group. The islet cells appeared normal with scarcely seen vacuolations. The duct system showed several changes; stratifications, invagination of the surface epithelium to the underlying connective tissue, and sprouting of the ductal epithelial cells in between the lobules. Numerous small islets were noticed in a close association with the intralobular ducts. Small newly lobules with abundant connective tissue were organized. There were significant increases in the insulin immunopositive β-cells and PCNA positive cells in PRP/diabetic group compared to diabetic group.Conclusion: This study provides an evidence of the diabetic pancreatic islet regeneration in response to PRP treatment. The PRP stimulated islet cell regeneration and stimulated the induction of other sources of β-cells generation as the exocrine portion of the pancreas; ductal and acinar cells. In addition, PRP might put the pancreas into an environment similar to the postnatal developmental one where new lobules were formed. These will pave the future for a novel treatment for diabetes.
Content may be subject to copyright.
OMICS International
Journal of Diabetes & Metabolism
J
o
u
r
n
a
l
o
f
D
i
a
b
e
t
e
s
&
M
e
t
a
b
o
l
i
s
m
ISSN: 2155-6156
El-Tahawy et al., J Diabetes Metab 2017, 8:3
DOI: 10.4172/2155-6156.1000730
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
Research Article
Abstract
Introduction: Diabetes mellitus is a global problem and several restoration approaches have been developed
to induce beta (β) cells regeneration. Platelet rich plasma (PRP) is an autogenous and economical source of growth
factors which nowadays used in the tissue repair.
Aim: To test the hypothesis that PRP could play a role in the improvement of the structural changes occurred in
the endocrine pancreas of experimentally- induced diabetic rats and the possible mechanisms through which PRP
induced its effects to shed a light on the possible use of such application in the clinical eld.
Material and methods: Sixty male albino rats were used; 20 for obtaining the PRP and 40 were divided into
4 equal groups (10 rats each): control, PRP-group, diabetic group, PRP/diabetic group. Diabetes was induced by
single intra-peritoneal injection of streptozotocin (50-60 mg/kg). The PRP was administered by SC injections in a
dose of 0.5 mg/kg twice weekly for 3 weeks.
Results: The diabetic group showed a signicant increase in blood glucose levels compared to the control.
Treatment with PRP signicantly reduced the blood glucose levels compared to the diabetic group. The diabetic
group showed variable marked morphological changes which diminished by the PRP administration. PRP/diabetic
group had a signicant increase in the mean number of pancreatic islets and β-cells/islet compared to the diabetic
group. The islet cells appeared normal with scarcely seen vacuolations. The duct system showed several changes;
stratications, invagination of the surface epithelium to the underlying connective tissue, and sprouting of the ductal
epithelial cells in between the lobules. Numerous small islets were noticed in a close association with the intra-
lobular ducts. Small newly lobules with abundant connective tissue were organized. There were signicant increases
in the insulin immunopositive β-cells and PCNA positive cells in PRP/diabetic group compared to diabetic group.
Conclusion: This study provides an evidence of the diabetic pancreatic islet regeneration in response to
PRP treatment. The PRP stimulated islet cell regeneration and stimulated the induction of other sources of β-cells
generation as the exocrine portion of the pancreas; ductal and acinar cells. In addition, PRP might put the pancreas
into an environment similar to the postnatal developmental one where new lobules were formed. These will pave the
future for a novel treatment for diabetes.
Effect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A
Histological and Immunohistochemical Study
Nashwa Fathy El-Tahawy1*, Rehab Ahmed Rifaai1, Entesar Ali Saber2, Saadia Ragab Saied1 and Randa Ahmed Ibrahim1
1Department of Histology and Cell Biology, Minia University, Minia, Egypt
2Department of Histology and Cell Biology, Minia University, delegated to Deraya University, New Minia, Egypt
*Corresponding author: Fathy El-Tahawy N, Department of Histology and Cell
Biology, Faculty of Medicine, Minia University, Minia, Egypt, Tel: 0201145435777;
E-mail: nashogo@yahoo.com
Received February 25, 2017; Accepted March 09, 2017; Published March 16,
2017
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017)
Effect of Platelet Rich Plasma (PRP) Injection on the Endocrine Pancreas of
the Experimentally Induced Diabetes in Male Albino Rats: A Histological and
Immunohistochemical Study. J Diabetes Metab 8: 730. doi: 10.4172/2155-
6156.1000730
Copyright: © 2017 El-Tahawy NF, et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original
author and source are credited.
Keywords: Diabetes mellitus; Streptozotocin; Platelet rich plasma;
Rats
Introduction
Diabetes mellitus (DM) is a global problem. It was the direct reason
of 1.5 million deaths in 2012 [1]. It is predicated that the number of
diabetic person in the world could reach up to 366 million by the year
2030 [2]. Type 1 diabetes results from the autoimmune destruction
of pancreatic beta (β) cells of the islets of Langerhans [3]. Exogenous
insulin is an important treatment for type1 diabetes but it is not a
physiological method to regulate the blood glucose levels, as it was not
administered in relation to glucose concentration. Beta cell replacement
therapies using either the pancreas or the islet transplantation were
used as a therapeutic alternative to the administration of exogenous
insulin [4]. However, these procedures associated with many problems
such as risks of major invasive surgery along with side eects of
immunosuppressive therapy [5]. Special alternative ways to generate
β-cells from endogenous sources should be found as a way for the
development of treatment. is is to avoid the complication of tissue
matching and surgical procedures [6]. To date several restoration
approaches have been developed to induce β-cells regeneration through
the induction of the proliferation of remaining β-cells, neo-genesis;
de novo islet formation from pancreatic progenitor cells, and trans-
dierentiation; converting non-β-cells within the pancreas to β-cells.
ese models of induction are the most simple, direct, and least invasive
ways to increase β-cell mass [7].
Streptozotocin (STZ) is a naturally occurring compound. It has
also been used as an antibiotic and cancer treatment. e STZ has
been widely used for inducing experimental diabetes mellitus [8].
Growth factors (GFs) are natural biological mediators that control
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 2 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
growth, dierentiation, and have role in the process of tissue repair and
regeneration [9]. Recently, long-term administration of a low dose of
epidermal growth factor (EGF) induces β-cell neo-genesis in diabetic
mice and induced ductal cell dierentiation into β- cells [10]. Platelets
convey many growth factors (GFs) [11]. Platelet-Rich Plasma (PRP)
is a low-cost procedure to deliver high concentrations of autologous
GFs [12]. PRP has been dened as an autologous concentration of
platelets that is 3 to 5 times greater than physiologic concentration of
thrombocytes in whole blood [13]. PRP therapy represents a relatively
new approach in regenerative medicine and accumulated considerable
attention over the two last decades [14]. It was used in many medical
and surgical elds [15] such as dentistry, orthopedics, neurosurgery,
ophthalmology, maxillofacial surgery, and cosmetic surgery [16].
PRP has been the subject in dierent studies in medicine, but there
was a lack of studies that handling the eect of PRP injection on the
diabetic pancreas. e aim of this was to test the hypothesis that PRP
could play a role in the improvement of the structural changes occurred
in the endocrine pancreas of experimentally-induced diabetic rats and
the possible mechanisms through which PRP induced its eects to shed
a light on the possible use of such application in the clinical eld.
Materials and Methods
Animals
is study was conducted in the Histology Department, Faculty
of Medicine, Minia University and carried on 60 adults male albino
Wistar rats weighing approximately 150-250 gm, of 8-10 weeks which
were pathogenically free. Animals were obtained from the animal house
of faculty of agriculture, Minia University. Rats were housed in clean
plastic cages and fed a standard laboratory diet with free access to water
and diet at room temperature with normal light/dark cycles. All aspects
of animal care and treatment were carried out according to the local
guidelines of the ethical committee of the Faculty of Medicine, Minia
University.
Reagents
Streptozotocin (STZ): A vial containing 1.5 g powder of STZ
and 220 mg citric acid (Sigma Aldrich, Egypt) which was freshly
dissolved in 0.1 M sodium citrate buer (pH 6) according to
the manufacture instructions and was used within 5 minutes of
preparation.
Anti-insulin antibody: A monoclonal mouse antibody, ultra-
vision one detection system, HRP Polymer & DAB plus
Chromogen (ermo Fisher Scientic, USA).
Anti-proliferating cell nuclear antigen (anti-PCNA): A
monoclonal mouse antibody, horseradish peroxidase coupled
to an inert polymer backbone & DAB Plus Chromogen (Dako-
EPOS, USA).
e platelet rich plasma (PRP) was freshly prepared.
Experimental design
Twenty male rats were used for obtaining PRP and the other 40 rats
were randomly divided into 4 equal groups (10 rats each):
e control group: Rats received i.p injections of citrate buer
saline in a dose of 0.5 ml /kg twice weekly for 3 weeks.
e PRP-group: Rats received PRP in a dose of 0.5 mL/kg by
subcutaneous injection (SC) injection twice weekly for 3 weeks.
e diabetic group: Rats received a single i.p injection of STZ
in a dose of 50-60 mg/kg body weight for induction of diabetes.
Aer 48 hours (considered day 0) of STZ injection, animals were
fasted overnight and blood samples were collected from the tail
vein and glucose levels were measured. Individual glucose levels
reached above 250 mg/dl was considered diabetic [16].
e PRP/diabetic group: Rats received a single i.p injection
of STZ in the same dose as the diabetic group. At day 0; aer
the conrmation of the induction of the diabetes, the PRP was
given in the same dose as PRP-group, twice weekly for 3 weeks.
Procedures
Preparation of PRP: e PRP preparation was performed at the
pharmacology department of faculty of medicine, Minia University.
e PRP preparation was carried out by adapting the protocol of the
double centrifugation tube method [17]. In brief, rats were anesthetized
with ether, 2 ml of blood was collected under aseptic technique from
the retro-orbital plexus using capillary tube initially dipped in 3.2%
sodium citrate, then collected into tubes containing 0.3 mL of the
anticoagulant. e blood was subjected to double centrifugation
method, in the rst centrifugation the tubes were centrifuged at 1600
revolutions per minute (rpm) for 10 minutes. is resulted in 3 dierent
density compartments; the inferior layer contained red blood cells, the
intermediate layer contained buy coat of white blood cells, and the
superior layer contained plasma. e plasma was pipetted and the
portion just above buy coat was obtained without disturbance of the
buy coat. e plasma was centrifuged again at 2000 rpm for 10 minutes.
is resulted in 2 parts: the top consisted of platelet-poor plasma (PPP)
and the bottom consisted of the platelet button. Part of the PPP was
discarded and part was remained in the tube along with platelet button
which then gently agitated to promote platelets resuspension. is
procedure resulted in the production of platelet-rich plasma (PRP). For
conformation of the platelet's concentration, 80 μL of the PRP sample
was counted in an automatic apparatus to verify that the platelet count
was greater than 1,000,000/μL.
e PRP administration: 0.5 ml PRP was dissolved in phosphate
buer saline (PBS) (PRP 1:1 PBS), then immediately aspirated
with micropipette, placed in a sterile insulin syringe, and injected
subcutaneously [18]. Rats were sacriced at the end of 3rd week for all
groups by decapitation under light halothane anesthesia. Pancreas was
rapidly removed and xed.
Biochemical study: Blood glucose levels were detected by the use
of one touch Accu-check glucometer® and compatible blood glucose
test strips [19]. At the beginning of the study, the blood glucose levels
were measured for all animals before grouping them to ensure that
the animals were all normoglycaemic. en blood glucose levels were
measured for the dierent study groups and measures were statistically
analyzed.
Histological study: Pancreatic specimens were xed in 10% buered
formalin for 24 hours, dehydrated in a graded alcohol series, cleared in
xylene, and embedded in paran. 5 μ-sections were mounted on glass
slides for further staining with haematoxylin and eosin (H&E) and
other sections with Masson trichrome according to Bancro et al. [20].
Immunohistochemical study: Other 5 μ-sections were used for
immunestaining. Briey [21] sections were deparanized in xylene,
rehydrated in descending grades of alcohol and immersed in 0.1%
hydrogen peroxide for 15 minutes to block the endogenous peroxidase
activity. en sections washed by phosphate buer, followed by
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 3 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
incubation in the ultravision block for 5 minutes at room temperature
to block the non-specic background staining. e primary antibody
(anti-insulin antibody) was diluted at 1:200 in antibody diluent while
the anti-PCNA antibody was ready to use. Sections were incubated in
the primary anti-insulin antibody for 30 minutes while incubated for 60
minutes with anti-PCNA antibody at room temperature. e reaction
was visualized using; Ultravsion one detection System, HRP Polymer
& diaminiobenzide (DAB) Plus Chromogen. Aer completion of the
reaction, counter staining was done using hematoxylin. Sections were
dehydrated by ascending alcohol concentrations, cleared by xylene, and
mounted. Positive cells for the anti-insulin antibody showed brown
cytoplasmic reaction and positive cells for the anti-PCNA antibody
showed brown nuclear reaction.
e positive control for anti-insulin was the normal pancreatic
tissue of the control animals while positive control for the anti-PCNA
antibody was the sections from colon of the control animals. For
negative control slides, the same steps were applied but the 1ry antibody
was not added to the pancreatic sections from the control group (gures
not included).
D-Morphometrical analysis: ree sections were examined from
each animal in the dierent groups. e morphomertrical studies were
made using Leica Qwin 500 Image Analyzer computer system (Leica
Microsystem Imaging Solution Ltd., Cambridge, UK).
Quantitative data were collected for 3 parameters
e number of islets per square millimeter of each section
e islets of the pancreas were counted in H&E slides randomly
under 10 power elds. e number of islets was assessed by
counting all islets per one square millimeter.
e number of β-cells in the islet
e β-cells of the pancreas were counted in the anti-insulin
immunostained sections under 40 power elds. e number of
β-cells was assessed by counting the nuclei of all positive cells
inside one islet in the eld. A total number of 30 islets for each
group were counted.
e number of PCNA positive cells in the islet
e PCNA positive cells in the islet of pancreas were counted in
the anti-PCNA immunostained sections under 40 power elds.
e brown nuclei inside one islet in the eld were counted. A
total number of 30 islets were counted for each group.
Statistical analysis: Quantitative data was analyzed by SPSS (IBM
Corp. Released 2010. Windows, Version 19.0). e mean and standard
deviation (sd) was calculated for the parameters of each group. Values
were expressed as means ± sd. One-way analysis of variance (ANOVA)
test was used for the detection of signicant dierences between groups,
followed by the use of Tukey-Kramar as a post hoc test. e results were
considered statistically signicant when the p-values were <0.05.
Results
Biochemical results
e PRP-group showed normal blood glucose levels with no
signicant dierence compared to the control group (p=0.900). ere
was a signicant increase in blood glucose levels aer STZ injection in
the diabetic group compared to the control group (p=0.0001). ere
was a signicant decrease in the blood glucose levels in the PRP/diabetic
group compared to the diabetic group (p=0.0001), but it showed a
signicant increase if compared to the control group (p=0.046).
Histological results
H&E and Masson trichrome stains results: H&E stained sections
from the control group (Figure 1a and 1b), showed normal histological
structure of the pancreatic tissue that was formed of lobules packed
with acini and separated from each other by a delicate connective
tissue. e islets of Langerhans appeared as pale stained rounded or
oval areas surrounded by the acini. e islets were formed of cords of
cells separated by blood capillaries. e main pancreatic duct was lined
by simple columnar epithelium resting on basement membrane and
surrounded by CT.
e PRP-group (Figure 1c and 1d), showed histological features
that nearly similar to the control group except that some blood vessels
appeared congested and the main pancreatic duct was dilated with wide
lumen and stagnant secretion. Some areas of stratication were noticed
in the lining epithelium.
In the diabetic group (Figure 2), STZ caused variable marked
morphological changes in the pancreatic tissue structure. ere was
widening of the inter-lobular spaces and the islets were less numerous.
Some islets became massively degenerated with a reduction of the cell
mass while others were completely devoid of cells. Dilatation of the
intra-lobular duct and numerous dilated blood vessels loaded with
RBCS and inammatory cells were seen in between the lobules. e
degenerated islets showed ballooned cells with vacuolated cytoplasm
and were separated with congested blood capillaries. Other islets
showed shrunken cells with acidophilic cytoplasm and pyknotic nuclei.
Fibroblast like cells were seen inltrating the islet. e main pancreatic
duct was dilated and had areas of stratication in its epithelial lining.
PRP administration to diabetic rats of the PRP/diabetic group
(Figure 3), resulted in marked improvement in the morphological
changes observed in the diabetic animals. Numerous islets of variable
sizes were seen. Some islets were observed connected to the nearby one
by stream of cells and appeared in close associations with the ducts. e
islet cells appeared normal with scarcely seen vacuolated cells. e duct
system showed several changes. Regarding the main pancreatic duct,
the lining epithelium showed increased stratications, invagination
of the surface epithelium to the underlying connective tissue, and
sprouting of the ductal epithelial cells in between the lobules. Numerous
intra-lobular ducts were dilated and had invaginations in their lining
epithelium. Some acini and islets enclosed within large amount of
connective tissue were noticed in close association with the wall of the
intra-lobular duct. Interestingly, scattered areas of the parenchyma had
begun to be organized into small lobules with abundant connective
tissue. is lobule was formed of aggregates of small acini, small ducts,
and numerous islets.
Sections of the pancreas stained with Masson trichrome from the
control group (Figure 4a and 4b) and PRP-group (Figure 4c and 4d)
revealed delicate collagen bers in the septa between lobules and in-
between acini. ey were also observed surrounding the intra-lobular
ducts, the blood vessels and in the wall of the main pancreatic duct.
ere were traces of delicate collagen bers surrounding the margins of
the islets and in between their cells. e diabetic group (Figure 4e and
4f) showed increased collagen deposition around the mentioned sites.
ere was extensive intra-islet collagen deposition forming strands
of brous tissue dividing the islets into nests of endocrine cells. e
PRP/diabetic group (Figure 5) showed a relative increase in collagen
deposition of the inter-lobular connective tissue, the peri-ductal
collagen bers, the intra-lobular ducts, and the blood vessel. In contrast
there was a decrease in the amount of collagen deposition within the
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 4 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
D
C
P
D
I
P
B
V
P
I
a
b
BV
200μ
c
s
Figures 1: Photomicrographs of rat pancreatic tissue:
a) Control group showing normal lobular architecture; islets of
Langerhans (IS) and the pancreatic acini (PA). Notice the interlobular
connective tissue (CT), the intra-lobular duct (D) and blood vessel
(BV).
b) The islet’s cells of the control group forming cords (black arrows)
separated by a network of blood capillaries (BC). The inset showing
the main pancreatic duct (pd) lined by simple columnar epithelium
(arrows) and surrounded by connective tissue (C). Notice the
c) basal basophilic (red arrows) and apical acidophilic cytoplasm
(yellow arrows) of pancreatic acinar cells.
d) The PRP-group showing preserved lobular architecture. Notice the
congested blood vessels (BV).
The PRP-group showing numerous blood capillaries (BC) in between the
cords of cells (arrows). Inset showing dilated main pancreatic duct
(pd) with areas of stratication (s) and stagnant secretion (star).
H&E, scale bar: a,c X200 μm; b,d, insets X50 μm.
d
E
a
b
c
e
f
Figure 2: Photomicrographs of rat pancreatic tissue of the diabetic group
showing:
a) Degenerated islets (IS), dilated intra-lobular duct (D) and congested
blood vessel (BV). Notice empty area of massively damaged islet
( E ) a n d w i d e i n t e r - l ob u l a r s p a c e s ( * ).
b) A degenerated islet showing numerous cells with vacuolated
cytoplasm (V) and some cells with densely acidophilic cytoplasm
(arrows).
c) Dilated inter-lobular spaces (*), degenerated islet (IS), inter-lobular
duct (D) and congested dilated blood vessel (B.V).
d) Congested and dilated blood vessel (BV) lled with RBCS (*) and
inammatory cell (arrows). Notice the stagnant secretion in the
inter-lobular duct (D).
e) Another islet showing deeply stained cells with pyknotic nuclei
(blue arrows). Notice the broblast like cells (black arrows)
inltrating between islet's cells.
f) Dilated main pancreatic duct (pd) with areas of stratication (s) in
its epithelial lining.
H&E, scale bar: a,c X200 μm; b,e X20μm; d,f X 0μm.
c
a
b
S
S
d
f
e
Figure 3: Photomicrographs of rat pancreatic tissue of the PRP/diabetic group showing:
Figure 3: Photomicrographs of rat pancreatic tissue of the PRP/diabetic group
showing:
a) Restored lobular architecture with numerous islets (arrows) associated
with intralobular ducts (D). Inset showing higher magnication of a
small islet.
b) Some islets are inter-connected with each other (arrows). Notice the
small duct (D). The inset shows higher magnication of a connecting
area between two islets.
c) An islet with numerous apparently normal cells (IC) and rich
vasculature (BC). Notice the scarcely vacuolated cells (arrow).
d) Increased stratications (S) in the epithelium lining of the main
pancreatic duct (pd), and the invagination of the surface epithelium
to the underlying connective tissue (black arrows). Notice the ductal
epithelial cells in between the lobules (red arrows) .
e) A dilated intra-lobular duct (d) with invagination of its epithelial lining
(arrow). Notice the acini (A) and islets (IS) in a relatively large amount
of connective tissue (CT).
f) An apparently newly formed small lobule containing small ducts (D),
some acini (A) and islets (IS) embedded in connective tissue (arrows).
H&E, scale bar: a,b X200 μm; c,e, inset X50 μm; d,f X100 μm
islet. Some areas had small clusters of endocrine cells closely associated
with the duct and each cluster was encapsulated by connective tissue.
e wall of the main pancreatic duct was invested with a large amount
of collagen bers compared to the control group.
Immunohistochemical study
Immunohistochemical analysis of sections immunostained
for insulin: e insulin secreting cells; β-cells, of the control group
(Figure 6a) and the PRP-group (Figure 6b) represented the major
cell population of the islets. e ductal epithelium showed negative
reaction. In the diabetic group (Figure 6c), some islets showed reduced
immune reactivity while others showed negative expression. e ductal
epithelium had also a negative reaction.
e PRP/diabetic group (Figure 7) showed increased immunostained
cells in the islet compared to the diabetic group. Scattered newly formed
small islets composed of positive cells were observed in the lobules. e
connection of cells that were observed connecting two islets had also
positive expression. ere was a positive expression in the epithelial
lining of the nearby intra-lobular ducts. Some immunostained cells
were observed forming a stream between the islets and the nearby ducts.
Surprisingly, few exocrine acinar cells showed positive expression.
Immunohistochemical analysis of sections immunostained for
PCNA: e control group (Figure 8a and 8b), showed few positive
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 5 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
these positive nuclei had atypical appearance with abnormal shape and
sizes.
In the diabetic group (Figure 8e and 8f), scarce immunopositive cells
were noticed in the islets, while the lining epithelium of intra-lobular duct
and the acinar cells showed numerous immunopositive nuclei.
a
c
e
b
d
f
c
Figure 4: Photomicrographs of rat pancreatic tissue showing collagen
bers in the septa between lobules, between acini (arrows), surrounding the
intralobular ducts (D) and blood vessels (BV) in : a ) Control group, c) The
PRP treated group, e) Diabetic group. Higher magnications showing the
islets and the inset showing the main pancreatic ducts of b) Control group,
d) The PRP -group. The diabetic group: e) Dense collagen deposition around
the congested dilated blood vessel (BV) and the inter-lobular ducts (D). f) The
extensive intra-islet collagen deposition (black arrows) forming strands dividing
the islet into nests of endocrine cells (N). The inset shows the main pancreatic
duct (pd) with extensive collagen (C) bers in its wall. Masson trichrome, scale
bar: a,c X200 μm; b,d,f X50 μm; e, insets X100 μm
a
D
50μ
b
c
d
c
Figure 5: Photomicrographs of rat pancreatic tissue of the PRP/diabetic group
showing:
a) A relative increase in collagen deposition surrounding lobules
(arrows) ,intra-lobular ducts (D) and blood vessel (BV).
b) An islet with little amount of collagen bers (black arrows) in between
islet cells. Notice prominent collagen bers (yellow arrow) around the
duct (D).
c) Small clusters of endocrine cells (C) encapsulated by connective
tissue (arrows ) and closely associated with the intra-lobular duct wall
(D).
d) The main pancreatic duct (pd) with extensive connective tissue rich in
collagen surrounding its wall (C).
Masson trichrome, scale bar: a,d X100 μm; b,c X50 μm
nuclear expression for PCNA in the cells of the islets and in the epithelial
lining of the intra-lobular ducts. In the PRP-group (Figure 8c and 8d),
more immunoreactive nuclei were noticed in the islets of Langerhans
and in the epithelial lining of the intra-lobular ducts. Unfortunately,
200μ
D
200μ
a
c
b
c
200μ
b
D
Figure 6: Photomicrographs of rat pancreatic tissue immunostained for insulin
of:
a) The control group, and b) The PRP-group; showing positive
immunostained β-cells (brown color) occupying most of the islet’s
tissue (black arrows) with negative reaction in the duct (D) and
acini (A). Inset is higher magnication of the positive immunostained
β-cells .
c) The diabetic group showing reduction in the immunohistochemical
expression in one islet (IS) and completely negative expression
in other islets (arrows). Inset showing marked reduction in the
expression in β-cells (arrows). Immunohistochemistry, counterstained
with H, scale bar: a,b,c X200 μm; insets, d X50 μm
a
d
μ
IS
IS
b
c
Figure 7: Photomicrographs of rat pancreatic tissue of the PRP/diabetic group
immunostained for insulin showing:
a) strong reaction in the islet’s cells (IS). Notice numerous small islets
scattered in the lobules (arrows).
b) two islets (IS) communicated to each other by immunopositive cells
(arrow).
c) immunopositive cells (arrows) in the islet (IS) and in the nearby
epithelium lining the intra-lobular duct (D) . Notice stream of
immunopositive cells in between the duct and the islet (arrows).
d) acini (A) and positive expression in two of acinar cells (arrows)
Immunohistochemistry, counterstained with H, scale bar: a,b
X200μm; c X50 μm; d X20 μm.
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 6 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
In the PRP/diabetic group, there was an apparent increase in
positive immunoreactive nuclei among the cells of the islets and in
the intra-lobular ductal lining epithelium. Some immunostained cells
appeared as a stream of positive nuclei that were crawling from the duct
towards the islet. Interestingly the connective tissue surrounding the
inter-lobular duct and cells of acini showed immunopositive reaction
(Figure 8g).
Morphometrical results
e number of islets per square millimeter (islets/mm2): ere
was no signicant dierence in the mean number of pancreatic islets/
mm2 of the PRP-group compared to the control group (p=1.068) but
there was a signicant decrease in the diabetic group compared to the
control group (p=0.001). On the other hand, there was a signicant
increase in the mean number of pancreatic islets in PRP/diabetic group
compared to both the control group (p=0.001) and diabetic1group
(p=0.0001) (Tables 1 and 2).
e number of insulin positive β-cells per islet: ere was no
signicant dierence in the mean number of anti-insulin positive
β-cells of the PRP-group compared to the control group (p=0.200),
but a signicant decrease in the mean number of immunopositive
β-cells in the diabetic group compared to the control group (p=0.0001)
200μ
b
a
50μ
IS
IS
c
50μ
d
50μ
*
*
50μ
e
f
g
Figure 8: Photomicrographs of rat pancreatic tissue immunostained for
PCNA of: a) The control group showing few immunoreactive nuclei in the
islet’s cells (arrows), and b) few immunoreactive nuclei in the epithelial lining
of the inter-lobular duct (arrow) and negative expression in the acini (A).
c) The PRP-group showing numerous islet cells (IS) with positive nuclear
expression. Notice atypical abnormal shape and size of nuclei (arrows), and
d) some immunopositive nuclei in the epithelium lining of the intralobular
duct. e) The diabetic group showing immunoreactive nuclei of islet cells
(arrows) and in the acinar cells (*), and f) immunoreactive nuclei in the lining
epithelium of intra-lobular duct (arrows). g) The PRP/diabetic group showing
many immunoreactive nuclei in the lining epithelium of the intralobular duct
(D) crawling towards the islet (red arrows) and among the islet’s cells (black
arrows). Immunohistochemistry, counterstained with H, scale bar: a,c,d,e,g
X50 μm; b,f X100 μm.
Blood glucose levels (mg/dl)
Mean ± sd p-value
Control group 93.4 ± 12.6
PRP-group 91.3 ± 12.5 0.900c
Diabetic group 393.3 ± 14.9 0.0001c*
PRP/diabetic group 167 ± 54.4 0.046 c*
0.0001d*
*p<0.05 is signicant, c versus the control group, and d versus the diabetic group.
Table 1: The blood glucose levels (mg/dl) in the studied groups (n=10).
was observed. On the other hand, there was a signicant increase in
the mean number of immunoreactive β-cells of PRP/diabetic group
compared to both the control group (p=0.046) and the diabetic group
(p=0.0001).
e number of PCNA positive cells per islet: ere was a
signicant increase in the mean number of PCNA positive cells in the
islets of PRP-group compared to control group (p=0.040). ere was
a signicant decrease in the diabetic group compared to the control
group (p=0.001). On the other hand there was a signicant increase
in the mean number of PCNA positive cells in the islets of PRP/
diabetic group compared to both the control and the diabetic group
(all p=0.000).
Discussion
Platelet rich plasma (PRP) is an autogenous and economical source
of growth factors which nowadays used in the tissue repair [12]. In this
study, the PRP preparation depended on double centrifugation method
that resulted in a platelet concentration 3 times higher than the initial
blood sample [17]. It was also depended on the endogenous activation
of platelets to allow the platelets to make their action spontaneously.
e repeated dose regimen provided a constant elevated level rather
than a sudden ood of growth factors [22].
In pancreatic disorders, there were pancreatic microcirculatory
disturbances and oxidative stress production which resulted in
congestion, extravasation of RBCs, and escape of tissue uids. ese
changes led to widening of the interlobular spaces with inammatory
cell inltration [23]. is was observed in the diabetic group beside the
extensive islet destruction. e STZ induced hyperglycemia by β-cells
destruction [24].
In terms of β-cell regeneration, the present results demonstrated
the eect of PRP injection on the regeneration and restoration of
pancreatic islet cell mass and claried the dierent mechanisms
through which PRP inuence the improvement of the diabetic damage
eects.
New islet cells could develop from progenitors through a process
called neo-genesis in postnatal life in rodent studies (Bonner-Weir et
al. [25]). e GFs were used to stimulate pancreatic β-cell proliferation
in vivo. ese molecules such as vascular endothelial growth factor
(VEGF) and connective tissue growth factor, had been investigated
as potential therapies for diabetes. It can stimulate β-cell proliferation
and insulin production [7]. Administration of PRP to the diabetic
rats in our study showed improvement of the pancreas and the islet
morphology. Numerous islets approached the corresponding healthy
pancreatic sections with an increase in β-cell number. Sections showed
increased positive PCNA cells; increased proliferation. Numerous
cells were functioning cells as the anti-insulin positive cells; β-cells,
represented the major cell population of the islets. Hyperplastic and
proliferative changes occurred in pancreas under the eect of certain
stressors or stimuli led to formation of recent β-cells (Jurczyk et al.
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 7 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
[26]). erefore, this study suggested that GFs of the PRP might act as
stimuli for proliferation of these cells that led to an increase in β-cells
number.
e pancreatic duct cells may serve as a source of regeneration
in adult rats by undergoing a reproducible trans-dierentiation into
β-cells [27]. β-cell progenitors located in the ductal lining epithelium
could be activated in the injured adult mouse pancreas (Xu et al. [28]).
In this study, the ductal epithelial lining showed areas of stratications
of the main pancreatic duct in the diabetic group which might be a
trial to increase the cell numbers as a way for regeneration of β-cells.
However, the capacity of the pancreas to regenerate was limited and the
exhaustion of cells led to diabetes because of the imbalance between ß
cell destruction and ß cell formation [29].
In the PRP/diabetic group, several areas of stratication and
invagination of the epithelial lining of the ducts were observed and
most of the islets and small clusters of endocrine cells were seen
closely associated with ducts. PCNA immunostained sections showed
increased positive cells in the lining epithelium of the intra-lobular
duct. Interestingly, a stream of PCNA-positive cells appeared as if
it was crawling from the duct towards the nearby islet through the
connective tissue between them. Furthermore, numerous cells in the
connective tissue showed insulin immunereactivity. ese ndings
could be claried by lineage-tracing data described by Xu et al. [28] who
mentioned that in adult pancreas some cells originate from hormone
progenitors present near ducts and become hormone-positive islet cells
in adult mice. is enforced our suggestion that platelet GFs released in
injured pancreas might act as stimuli for ductal stem cell activation and
its further dierentiation. is was in agreement with Song et al. [30]
who reported that the TGF-α; one of PRP GFs, induced the expansion
of ductal cells leading to an increase of areas of islet in a process of
neogenesis.
In addition, some acini in our results had PCNA positive cells
and some insulin positive cells in their lining. Acinar cells could be
converted to mature β-cells aer injury as a compensatory mechanism
[31]. Acinar to endocrine conversion was demonstrated using in
vitro cultured primary acinar cells treated with GFs such as EGF.
Accordingly, endocrine cells can regularly be detected in exocrine cells
in each rodents and humans [32].
e ndings of this study were in line with Jurczyk et al. [26]
who found that the histological studies on human tissue in adult who
exposed to any stress factors showed insulin-expressing cells in ducts,
isolated β-cells in the pancreatic parenchyma, and small islet clusters.
PRP had consistently shown to potentiate stem cell proliferation,
migration, and dierentiation (Masoudi et al. [33]). e PRP peptide
GFs such as EGF were the principal external indicators that activate the
mitogen-activated protein kinase and had a role in trans-dierentiation
of pancreatic acinar and ductal cells into endocrine islet cells (Abban-
Mete et al. [34]). Another one of PRP GFs; insulin growth factor,
localized to the focal areas of regeneration and may play an important
role in pancreatic regeneration by autocrine mechanisms through
stimulation of DNA synthesis [35]. is could take place by using
replication of already dierentiated β-cells (β-cell plasticity) or neo-
genesis from putative islet stem cells in the ductal or acinar epithelium
[26].
erefore, PRP could restore β-cells by stimulating the dierent
sources of β-cells progenerators in adult rat through proliferation and
trans-dierentiation process. is was in contrast to others [36,37] who
suggested that adult pancreatic β-cells are formed by self-duplication
rather than stem-cell dierentiation. Also, it was in opposing to Kopp
et al. [37] who reported that the derivation of endocrine cells from the
ducts occurred only in early postnatal life, but no endocrine or acinar
cell neo-genesis occurred in adult mice either physiologically or aer
pancreatic duct ligation.
For assessment of the role of the PRP injection in stimulation of
extracellular matrix formation in pancreatic tissues, Masson trichrome
stain was used. Aer STZ injection in the diabetic group, extensive
collagen depositions were observed. In diabetes, there was inter-acinar
and inter-lobular brosis which suggesting that insulinopenia might
cause these injurious eects on exocrine pancreas [38]. Concerning
this issue, previous reports localized the pancreatic stellate cell (PSCs)
in the islets. Upon activation, PSCs started to proliferate, change their
morphology into myobroblast-like cells, and start to secrete extra
cellular matrix components [39].
In this study, broblast-like cells were seen invading some islets.
is observation could explain the extensive intra-islet collagen
deposition forming strands of brous tissue which divided the islets
into nests of endocrine cells. Kim et al. [40] in their study owed the
brotic changes to activation and proliferation of the PSCs. Invasions
of the pancreatic islets by these cells resulted in brotic islet destruction
that led to the limited capacity of β-cell proliferation and accelerated
apoptosis in diabetic patients. is was responsible of delaying a
complete tissue restoration in diabetes [41].
Activated PSCs subsequently develop functional alterations
including: increased proliferation and migration, synthesis of excessive
ECM proteins (collagen, bronectin, laminin), secretion of GFs and
cytokines which exert both paracrine and autocrine eects to enhance
the cell growth and migration [42]. In our study, PRP/diabetic group
revealed an obvious decrease in collagen deposition in the islet and a
relative increase in the peri-ductal collagen and within the inter-lobular
connective tissue.
e increased vasculature observed in this group could be explained
by Bir et al. [43] results who mentioned that injection of PRP resulted
in increasing the neo-vascularization due to release of VEGF.
One of the most characteristic ndings of this work was the
appearance of aggregates of small acini, small ducts, and numerous small
islets/m2β-cells/islet PCNA +ve cells/islet
Mean ± SD p-value Mean ± SD p-value Mean ± SD p-value
Control group 2.5 ± 0.97 88.7 ± 8.7 5.9 ± 3.1
PRP-group 2.5 ± 0.85 1.068c 94 ± 7.5 0.200c 8.5 ± 6.1 0.040c*
Diabetic group 1 ± 0.85 0.001c* 23.6 ± 22.8 0.0001c* 1.2 ± 1.8 0.001c*
PRP/diabetic group 4.4 ± 0.96 0.001c*
0.0001d* 104.50 ± 21.9 0.046 c*
0.0001d* 24.1 ± 6.6 0.0001c*
0.0001d*
*p<0.05 is signicant. cversus the control group. d versus the diabetic group.
Table 2: The number of iselts per square millimeter (islets/m2), insulin positive β-cells per islet (β-cells/islet), and PCNA
positive cells per islet (PCNA +ve cells/islet) in the studied groups (n=10).
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 8 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
islets abundant connective tissue arranged into small lobules. ese
results could provide an evidence of new lobule formation through
PRP activation of ECM formation together with the neovascularization
in order to build a scaold for the proliferated progenitors in the
ducts. en the ductal epithelium gives rise to all pancreatic epithelial
lineages, i.e. duct, acinar and endocrine cells [44]. ese were similar to
Hardikar, who described the same consequence for endocrine pancreas
development during the postnatal period. erefore, this could support
our suggestion that the PRP administration might put the pancreas in
an environment similar to the postnatal period of development.
Regarding the morphometric results of this study, two important
observations must be taken in consideration: in the PRP/diabetic
group there was signicant increase in the number of PCNA positive
cells compared to controls. erefore, its recommended to perform
several studies for adequate adjustment of the dose and duration of
PRP therapy before its clinical application. e PRP-group exhibited
increased PCNA positive cells which had atypical shape and size of
nuclei. erefore, our study recommends not to inject the PRP in
normal conditions to avoid overstimulation of cell proliferation, which
could lead to hyperplasia or tumor formation.
Conclusion
is study provides an evidence of the diabetic pancreatic islet
regeneration in response to PRP treatment. e PRP stimulated islet cell
regeneration and stimulated the induction of other sources of β-cells
generation as the exocrine portion of the pancreas; ductal and acinar
cells. In addition, PRP might put the pancreas into an environment
similar to the postnatal developmental one where new lobules were
formed. ese will pave the future for a novel treatment for diabetes.
Recommendations
Some limitations to this study were acknowledged. Further
studies are required to identify the exact mechanisms responsible for
these results and to conrm the process of neo-genesis and trans-
dierentiation among pancreatic cells.
Conicts of Interest
ere is no conict of interest to declare.
References
1. WHO (2016) Global report on diabetes. Retrieved January 1, 2017, from World
Health Organization 21: 10-61.
2. Patel D, Kumar R, Laloo D, Hemalatha S (2012) Diabetes mellitus: An
overview on its pharmacological aspects and reported medicinal plants having
antidiabetic activity. Asian Pacic Journal of Tropical Biomedicine 2: 411-420.
3. Bender C, Christen S, Scholich K, Bayer M, Pfeilschifter JM, et al. (2016) Islet-
Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in
Mice With Type 1 Diabetes. Diabetes 66: 113-126.
4. Pagliuca F, Millman J, Gürtler M, Segel M, Van Dervort A, et al. (2014)
Generation of Functional Human Pancreatic β Cells In Vitro Cell. Pancreatic
disorders and therapy 159: 428-439.
5. Okere B, Lucaccioni L, Dominici M, Iughetti L (2016) Cell therapies for
pancreatic beta-cell replenishment Italian. Journal of Pediatrics 42: 18-21.
6. Pagliuca FW, Melton DA (2013) How to make a functional β-cell Development.
Journal of endocrinology 140: 2472-2483.
7. Márquez-Aguirre A, Canales-Aguirre A, Padilla-Camberos E, Esquivel-Solis H,
Díaz-Martínez N (2015) Development of the endocrine pancreas and novel
strategies for β-cell mass restoration and diabetes therapy. Brazilian Journal of
Medical and Biological Research 48:765-776.
8. Goud, BJ, Dwarakanath M, Chikk swamy K (2015) Streptozotocin - A
Diabetogenic Agent in Animal Models. Human Journals Review article 3: 253-
269.
9. Mani R, Mahantesha S, Nandini TK, Lavanya R (2014) Growth Factors in
Periodontal Regeneration. Journal of Advanced Oral Research 5: 1-5.
10. Zhang M, Lin Q, Qi T, Wang, T, Chen C, et al. (2016) Growth factors and
medium hyperglycemia induce Sox9+ductal cell differentiation into β cells
in mice with reversal of diabetes. Proceedings of the National Academy of
Sciences 113: 650-655.
11. Sonker A, Dubey A, Bhatnagar A, Chaudhary R (2015) Platelet growth factors
from allogeneic platelet-rich plasma for clinical improvement in split-thickness
skin graft. Asian Journal of Transfusion Science 9:155-158.
12. Cavallo C, Rof A, Grigolo B, Mariani E, Pratelli L, et al. (2016) Platelet-Rich
Plasma: The Choice of Activation Method Affects the Release of Bioactive
Molecules. BioMed Research International 1-7.
13. Knezevic NN, Candido KD, Desai R, Kaye AD (2016) Is Platelet-Rich Plasma
a Future Therapy in Pain Management. Medical Clinics of North America 100:
199-217.
14. Pavlovic V, Ciric M, Jovanovic V, Stojanovic P (2016) Platelet rich plasma: A
short overview of certain bioactive components. Open Medicine 11: 242-247.
15. Redaelli A, Romano D, Marciano A (2010) Face and neck revitalization with
platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively
treated patients. J Drugs Dermatol 9: 466-472.
16. Ukwenya V, Ashaolu O, Adeyemi D, Abraham K (2015) Experimental diabetes
and the epididymis of Wistar rats: The protective effects of Anacardium
occidentale (Linn). Journal of Experimental and Clinical Anatomy 14: 57.
17. Pazzini JM, Nardi AB, Huppes RR, Gering AP, Ferreira MG, et al. (2016) Method
to obtain platelet-rich plasma from rabbits (Oryctolagus cuniculus). Pesquisa
Veterinária Brasileira 36: 39-44.
18. Hesami Z, Jamshidzadeh A, Ayatollahi M, Geramizadeh B, Farshad O, et al.
(2014) Effect of Platelet-Rich Plasma on CCl 4 -Induced Chronic Liver Injury in
Male Rats. International Journal of Hepatology 14: 1-7.
19. Attia H, Al-Rasheed N, Al-Rasheed N, Faddah L (2015) The combination of
zinc and glibenclamide limits cardiovascular complications in diabetic rats via
multiple mechanisms. Pak J Pharm Sci 28: 499-508.
20. Bancroft JD, Suvarna S, Kim Layton C (2013) Bancroft’s Theory and Practice of
Histological Techniques China: Churchill Livingstone. Elsevier 5: 6-10.
21. Cemek M, Kağa S, Şimşek N, Buyukokuroğlu ME, Konuk M (2008)
Antihyperglycemic and antioxidative potential of Matricaria chamomilla L in
streptozotocin-induced diabetic rats. Journal of Natural Medicines 62: 284-293.
22. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM (2009) Use of
Autologous Platelet-rich Plasma to Treat Muscle Strain Injuries. The American
Journal of Sports Medicine 37: 1135-1142.
23. Zhou ZG, Chen YD, Sun W, Chen Z (2002) Pancreatic microcirculatory
impairment in experimental acute pancreatitis in rats World. Journal of
Gastroenterology 8: 933-936.
24. Rifaai RA, El-Tahawy NF, Saber EA, Ahmed R (2012): Effect of Quercetin on
the Endocrine Pancreas of the Experimentally Induced Diabetesin Male Albino
Rats: A Histological and Immunohistochemical Study. J Diabetes Metab 3: 182-
193.
25. Bonner-Weir S, Li W, Ouziel-Yahalom L, Guo L, Weir GC, et al. (2010) Cell
Growth and Regeneration: Replication Is Only Part of the Story Diabetes 59:
2340-2348.
26. Jurczyk A, Bortell R, Alonso LC (2014) Human β-cell regeneration: progress,
hurdles, and controversy Current Opinion in Endocrinology & Diabetes and
Obesity. J Diab Metab 21: 102-108.
27. Juhl K, Bonner-Weir S, Sharma A (2010) Regenerating pancreatic
β-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo
neogenesis. Current Opinion in Organ Transplantation 15: 79-85.
28. Xu X, D'Hoker J, Stangé G, Bonné S, De Leu N, et al. (2008) β Cells Can
Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas
Cell. American Journal of Diabetes 132: 197-207.
29. Risbud MV, Bhonde RR (2002) Models of pancreatic regeneration in
diabetes. Diabetes Research and Clinical Practice 58: 155-165.
Citation: El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA (2017) TEffect of Platelet Rich Plasma (PRP) Injection on the Endocrine
Pancreas of the Experimentally Induced Diabetes in Male Albino Rats: A Histological and Immunohistochemical Study. J Diabetes Metab
8: 730. doi: 10.4172/2155-6156.1000730
Page 9 of 9
Volume 8 • Issue 3 • 1000730
J Diabetes Metab, an open access journal
ISSN: 2155-6156
30. Song SY, Gannon M, Washington M, Scoggins CR, Meszoely IM et al.
(1999) Expansion of Pdx1-expressing pancreatic epithelium and islet
neogenesis in transgenic mice overexpressing transforming growth factor. Α
Gastroenterology 117: 1416-1426.
31. Pan FC, Bankaitis ED, Boyer D, Xu X, Van de Casteele M, et al. (2013)
Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells
during pancreas organogenesis and injury-induced facultative restoration
Development 140: 751-764.
32. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta
cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence
for islet regeneration. Diabetologia 48: 2221-2228.
33. Masoudi EA, Ribas J, Kaushik G, Leijten J, Khademhosseini A (2016)
Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and
Regeneration. Current Stem Cell Reports 2: 33-42.
34. Abban-Mete G, Erdogan D, Cam M, Ozogul C (2013) The Effects of Epidermal
Growth Factor on Pancreas in Alloxan- Diabetic Rats: An Ultrastructural
Study. Journal of Endocrinology and Diabetes Mellitus 1: 27-32.
35. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, et al. (2002) β cell
expression of IGF-I leads to recovery from type 1 diabetes. Journal of Clinical
Investigation 109: 1153-1163.
36. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic β-cells are formed
by self-duplication rather than stem-cell differentiation Nature 429: 41-46.
37. Kopp JL, Dubois CL, Schaffer AE, Hao E, Shih HP, et al. (2011) Sox9+
ductal cells are multipotent progenitors throughout development but do
not produce new endocrine cells in the normal or injured adult pancreas
Development. Journal of Gastroenterology 138: 653-665.
38. Riccillo FL, Bracamonte MI, Console GM, Gómez Dumm CL (2004)
Histomorphological and quantitative immunohistochemical changes in the rat
pancreas during aging Biocell. Journal of Endocrinology and Diabetes 28: 127-
134.
39. Apte M, Pirola R, Wilson J (2009) New insights into alcoholic pancreatitis and
pancreatic cancer Journal of Gastroenterology and Hepatology 24: 51-56.
40. Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, Hara M (2009) Islet architecture: A
comparative study Islets. Journal of Gastroenterology 1: 129-136.
Citation: Ludwig C, Streicher M, Habicht SD, Swai ME, Krawinkel MB (2017)
Targeted screening reveals high numbers of prediabetes and diabetes mellitus
in Moshi, Tanzania. J Diabetes Metab 8: 720. doi: 10.4172/2155-6156.1000720
OMICS International: Open Access Publication Benefits &
Features
Unique features:
Increased global visibility of articles through worldwide distribution and indexing
Showcasing recent research output in a timely and updated manner
Special issues on the current trends of scientic research
Special features:
700+ Open Access Journals
50,000+ Editorial team
Rapid review process
Quality and quick editorial, review and publication processing
Indexing at major indexing services
Sharing Option: Social Networking Enabled
Authors, Reviewers and Editors rewarded with online Scientic Credits
Better discount for your subsequent articles
Submit your manuscript at: http://www.omicsonline.org/submission
... Additionally, algMC was supplemented with different proteins and growth factors, specifically bovine serum albumin (BSA), human platelet lysate (PL), and human fresh frozen plasma (FFP). The choice of supplements is based on the observation of an increase in viability and insulin secretion when murine islets were exposed to human serum albumin [39], and an improved blood-glucose control after injections of platelet-rich plasma into diabetic rats [40,41]. ...
... Taken together, the viability data ( Figure 2) show that the algMC blend adequately maintains viability and morphology of NICC equivalent to suspension culture. However, literature suggests that supplementation with proteins such as albumin [39] or proteingrowth factor mixtures such as PRP [40,59] can lead to an increase in viability, β-cell proliferation, and insulin secretion in adult murine pancreatic islets. It is therefore feasible, that the addition of such supplements might also increase viability in bioprinted NICC. ...
... For rat islets in vitro, this resulted in an increased viability, as well as an increased insulin content and release with no reported SI [59]. In vivo, when diabetes was induced in rats, the injection of PRP led to an increase in the number of β-cells, increased insulin secretion, improved blood-glucose control, and reduced oxidative stress [40,41,59,62]. A positive effect on the number of β-cells was also observed when PRP was added during the differentiation of induced pluripotent stem cells [63]. ...
Article
Full-text available
The transplantation of pancreatic islets can prevent severe long-term complications in diabetes mellitus type 1 patients. With respect to a shortage of donor organs, the transplantation of xenogeneic islets is highly attractive. To avoid rejection, islets can be encapsulated in immuno-protective hydrogel-macrocapsules, whereby 3D bioprinted structures with macropores allow for a high surface-to-volume ratio and reduced diffusion distances. In the present study, we applied 3D bioprinting to encapsulate the potentially clinically applicable neonatal porcine islet-like cell clusters (NICC) in alginate-methylcellulose. The material was additionally supplemented with bovine serum albumin or the human blood plasma derivatives platelet lysate and fresh frozen plasma. NICC were analysed for viability, proliferation, the presence of hormones, and the release of insulin in reaction to glucose stimulation. Bioprinted NICC are homogeneously distributed, remain morphologically intact, and show a comparable viability and proliferation to control NICC. The number of insulin-positive cells is comparable between the groups and over time. The amount of insulin release increases over time and is released in response to glucose stimulation over 4 weeks. In summary, we show the successful bioprinting of NICC and could demonstrate functionality over the long-term in vitro. Supplementation resulted in a trend for higher viability, but no additional benefit on functionality was observed.
... After the preparation of PRP, it was applied subcutaneously (0.5ml/kg BW). Platelets naturally precipitate, clump, and get activated, thereby releasing the GFs contained within alpha granules [18]. ...
Article
Full-text available
Background The current study was designed to highlight the effects of heterologous platelet-rich plasma (PRP) on deteriorated hepatic tissues and impaired glucose metabolism of alloxan-induced diabetic mice. Methods 30 male mice were divided into a control (CG), PRP (PG), diabetic (DG), and two treated groups (T1G and T2G). PG was given PRP treatment (0.5 ml/kg body weight) twice a week for four weeks. DG, T1G and T2G were given alloxan (150 mg/kg) to induce diabetes. After confirmation, PRP treatment was given to T1G and T2G for two and four weeks respectively while DG was left untreated. Upon completion of the said experimental period, liver samples were taken for histological and gene expression analyses. Results The study found that the liver tissue of the DG group showed signs of damage, including hepatocyte ballooning, sinusoid dilatation, and collagen deposition. However, these changes were significantly reduced in both T1G and T2G groups. The expression of several genes related to liver function was also affected, with upregulation of Fbp1 and Pklr, and downregulation of Pck1 in the DG group. PRP treatment restored Fbp1 expression and also increased the expression of glycolytic pathway genes Hk1 and Gck, as well as Wnt signalling pathway genes Wnt2, Wnt4, and Wnt9a in both treated groups. Conclusion Current study revealed that heterologous PRP may partly alleviate high glucose levels in diabetics possibly by mediating glucose metabolism via inhibition of Wnt signalling pathway.
... The regeneration capability of PRP is being influenced by the endogenous stimulation of platelets to permit a spontaneous action (Younis, 2019). The multiple-dose regimen offered a continuously high level of growth factors rather than single abrupt flooding (El-Tahawy et al., 2017). Moreover, autologous PRP has been used to evaluate its role in healing processes but in case of compromised physiological conditions, alternate sources are recommended for PRP preparation. ...
Article
Full-text available
ARTICLE DETAILS Pediatric surgical wound care is a critical aspect of medical practice, necessitating innovative approaches to optimize healing and minimize complications. Platelet-rich plasma (PRP) therapy has emerged as a promising intervention for enhancing wound healing in pediatric patients. This review comprehensively evaluates the efficacy, underlying mechanisms, and challenges associated with platelet-rich plasma (PRP) therapy in the context of pediatric surgical wounds. Platelet-rich plasma (PRP), a biologic concentrate enriched with growth factors and cytokines, plays a pivotal role in wound healing by promoting cell proliferation, differentiation, and tissue regeneration. This article explores the mechanisms of action of this therapy in detail, focusing on its immunomodulatory effects and interaction with growth factors, and highlighting the significance of factors influencing platelet-rich plasma (PRP) efficacy, This article also gives examples of platelet-rich plasma (PRP) therapy in various pediatric surgical procedures, summarizes outcomes from clinical studies and trials, and addresses safety concerns and potential adverse effects associated with platelet-rich plasma (PRP) therapy in pediatric surgical wound management. In conclusion, this review underscores the potential of platelet-rich plasma (PRP) therapy as an adjunctive treatment in pediatric surgical wound care. By elucidating its mechanisms, clinical efficacy, and challenges, the review provides insights for clinicians and researchers to guide evidence-based practice. Recommendations for future research and the integration of platelet-rich plasma (PRP) therapy into clinical guidelines emphasize the importance of refining protocols, ensuring cost-effectiveness, and adhering to ethical standards in pediatric surgical wound care.
Article
Full-text available
Background: Pyogenic liver abscesses are insidious in the early stage. Some cases progress rapidly, and the patient's condition can worsen and even become life-threatening if timely treatment is not provided. Surgery and prolonged antibiotic treatment are often required if the abscess is large and liquefied and becomes separated within the lumen. Case summary: We report a case of bacterial liver abscess with a poor outcome following pharmacological treatment, review the literature related to the use of platelet-rich plasma (PRP) in the treatment of hepatic impairment and partial hepatectomy in animals, and discuss the prognostic features of surgical incision and drainage combined with PRP in the treatment of bacterial liver abscesses. This is the first case describing the use of PRP in the treatment of a bacterial liver abscess in humans, providing new ideas for the treatment of this condition. Conclusion: This case highlights the importance of surgical treatment for bacterial liver abscesses that are well liquefied and poorly managed medically. PRP may produce antimicrobial effects and promote the regeneration and repair of liver tissue.
Article
Full-text available
Type II diabetes mellitus (T2DM) is known as non-insulin dependent diabetes mellitus. Insulin impairment and insulin resistance are the major causes of type II diabetes mellitus. People with T2DM are more prone to macro-vascular and micro vascular impediments. Adult Autologous Adipose derived stem cells (ADSC) hold potential to develop into multilineages and they can secrete numerous growth factors that can regenerate the damaged neighboring cells. The chronic wound healing processes and diabetes-associated complications are reported to be treated by using stem cells by revascularization and by promoting the micro vascular remodeling. Objective: To evaluate the safety and efficacy of Adipose derived autologous stem cells and PRP in patients suffering from Type 2 Diabetes Mellitus (T2DM). Methods: We reported three cases aged 50, 69 and 72 years suffering from T2DM since 20, 10 and 20 years respectively. They were treated with adult autologous ADSC and Platelets Rich Plasma (PRP). Results: Over a follow up of twelve months significant control in glycemia as well as stable glycosylated hemoglobin with decrease in pain on Visual Analogous scale (VAS) score has been observed
Article
Radiation-induced damage to salivary glands (SG) is a consequence of radiotherapy for head and neck cancers. Recovery of the irradiated SG has been studied using various regenerative approaches. This study aims to compare the regenerative potentials of platelet-rich plasma (PRP) and bone marrow mononuclear cells (BMMCs) on irradiated rat submandibular salivary glands (SMD). 32 healthy male albino rats were irradiated with a single dose of 6 Gy then classified into four groups. Group A received no treatment while the other 3 groups were injected 24 hours post-radiation with a single dose of either; BMMCs (Group B), PRP (Group C), or BMMCs suspended in PRP (Group D). SMD regeneration was assessed in terms of histological changes and TGF- β1 gene expression. The results showed that compared to the untreated group all groups showed successful regeneration with group D showing the best results. A statistically significant increase in the surface area of acini and TGF- β1 gene expression was observed in group D, followed by group C, then B. Our results prove that using PRP and BMMCs could be promising in decreasing irradiation side effects on SG. Moreover, combining PRP and BMMCs gives better effects compared to each therapy alone.
Article
Renal ischemia-reperfusion (I-R) injury is the main cause of acute renal failure. Acute pancreatitis is one of the fatal remote lesions that occurs in patients with renal I-R injury. Platelet-rich plasma (PRP) is a hopeful aiding therapy for tissue injuries. Forty adult rats were utilized in this study, ten for PRP preparation and thirty were divided into three groups; Control: subdivided into three equal subgroups, I-R group: exposed to bilateral renal pedicles clamping and I-R+ PRP group: were experienced identical procedures as I-R group then subcutaneously (S.C) injected with 0.5 ml PRP two times weekly for three weeks. Blood samples were taken for detection of serum urea and creatinine, blood glucose level and serum amylase. The pancreas was dissected and prepared for histopathological examination by light and electron microscope. Statistical analysis of all collected results was performed. Our biochemical results revealed deleterious effects of renal I-R on the pancreas as evidenced by a highly significant increase in serum amylase and blood glucose level. In I-R group, histopathological examination revealed wide septa and congested blood vessels, acinar cells showed disrupted rough endoplasmic reticulum and few secretory granules. Some islet cells showed pyknotic nuclei and vacuolated cytoplasm. PRP treated group showed nearly normal structure in the form of numerous acinar cells' granules, extensive rough endoplasmic reticulum and mitochondria. Most of Beta cells had euchromatic nuclei and numerous secretory granules. Accordingly, PRP treatment reduced the pancreatic biochemical and histopathological alterations caused by renal I-R injury and so considered a promising therapy for pancreatic damage.
Article
Full-text available
Free radicals and reactive oxygen species (ROS) are the cause of diseases such as cancer, diabetes, cardiovascular and inflammatory. The presence of an increase in the number of free radicals and excess ROS production in the body can cause an imbalance of the immune system. Therefore, additional antioxidants are needed from outside the body. During this time there are several antioxidant synthesis drugs such as (Butyl Hydroxy Anisole) BHA and (Butyl Hydroxyl Toluene) BHT. But in its use, this drug causes side effects. Therefore, it is necessary to source antioxidants that have no side effects if consumed. PRP is a product produced from fresh whole blood that contains components of Red blood cells, White blood cells, Platelets, and Plasma. Plasma contains organic and inorganic molecules and ions wherein abundant conditions serve to transport other substances. To determine the ability of PRP as an antioxidant, fractionation, and bioactivity tests for free radical capture of 1,1-diphenyl-2-picrilhydrazil (DPPH) and color decay tests at 2,2'-azino-bis-[3-ethylbenzotiazolin sulfonate] (ABTS) in vivo.. Based on the results of this study, PRP has antioxidant activity that increases along with the decrease in THE concentration of PRP with an antioxidant activity value of 10.57% with the DPPH test and 5.85% with the ABTS test at the lowest concentration (6.25 μg / mL). IC50 averages 190.29 μg/mL with DPPH test and 126.60 μg/mL with the ABTS test. The results of this study are an indication that PRP can be used as a treatment therapy related to the anti-oxidant activity.
Article
Full-text available
Platelet-Rich Plasma (PRP) is a low-cost procedure to deliver high concentrations of autologous growth factors (GFs). Platelet activation is a crucial step that might influence the availability of bioactive molecules and therefore tissue healing. Activation of PRP from ten voluntary healthy males was performed by adding 10% of CaCl 2 , 10% of autologous thrombin, 10% of a mixture of CaCl 2 + thrombin, and 10% of collagen type I. Blood derivatives were incubated for 15 and 30 minutes and 1, 2, and 24 hours and samples were evaluated for the release of VEGF, TGF- β 1, PDGF-AB, IL-1 β , and TNF- α . PRP activated with CaCl 2 , thrombin, and CaCl 2 /thrombin formed clots detected from the 15-minute evaluation, whereas in collagen-type-I-activated samples no clot formation was noticed. Collagen type I produced an overall lower GF release. Thrombin, CaCl 2 /thrombin, and collagen type I activated PRPs showed an immediate release of PDGF and TGF- β 1 that remained stable over time, whereas VEGF showed an increasing trend from 15 minutes up to 24 hours. CaCl 2 induced a progressive release of GFs from 15 minutes and increasing up to 24 hours. The method chosen to activate PRP influences both its physical form and the releasate in terms of GF amount and release kinetic.
Article
Full-text available
Platelet rich plasma (PRP) represents a relatively new approach in regenerative medicine. It is obtained from patient’s own blood and contains different growth factors and other biomolecules necessary for wound healing. Since there are various protocols for PRP preparing, it usually results with PRP generation with different amounts of bioactive substances, which finally may modulate the intensity of wound healing. The reference data about potential effect of some PRP compounds on wound healing, in different tissues, are still controversial. This review summarizes recently known facts about physiological role of certain PRP components and guidance for further research. Also, this review discusses different procedure for PRP generation and potential effect of leukocytes on wound healing.
Article
Full-text available
The current treatment approach for type 1 diabetes is based on daily insulin injections, combined with blood glucose monitoring. However, administration of exogenous insulin fails to mimic the physiological activity of the islet, therefore diabetes often progresses with the development of serious complications such as kidney failure, retinopathy and vascular disease. Whole pancreas transplantation is associated with risks of major invasive surgery along with side effects of immunosuppressive therapy to avoid organ rejection. Replacement of pancreatic beta-cells would represent an ideal treatment that could overcome the above mentioned therapeutic hurdles. In this context, transplantation of islets of Langerhans is considered a less invasive procedure although long-term outcomes showed that only 10 % of the patients remained insulin independent five years after the transplant. Moreover, due to shortage of organs and the inability of islet to be expanded ex vivo, this therapy can be offered to a very limited number of patients. Over the past decade, cellular therapies have emerged as the new frontier of treatment of several diseases. Furthermore the advent of stem cells as renewable source of cell-substitutes to replenish the beta cell population, has blurred the hype on islet transplantation. Breakthrough cellular approaches aim to generate stem-cell-derived insulin producing cells, which could make diabetes cellular therapy available to millions. However, to date, stem cell therapy for diabetes is still in its early experimental stages. This review describes the most reliable sources of stem cells that have been developed to produce insulin and their most relevant experimental applications for the cure of diabetes.
Article
Full-text available
Platelet-rich plasma (PRP) is a product easy and inxpesnsive, and stands out to for its growth factors in tissue repair. To obtain PRP, centrifugation of whole blood is made with specific time and gravitational forces. Thus, the present work aimed to study a method of double centrifugation to obtain PRP in order to evaluate the effective increase of platelet concentration in the final product, the preparation of PRP gel, and to optimize preparation time of the final sample. Fifteen female White New Zealand rabbits underwent blood sampling for the preparation of PRP. Samples were separated in two sterile tubes containing sodium citrate. Tubes were submitted to the double centrifugation protocol, with lid closed and 1600 revolutions per minute (rpm) for 10 minutes, resulting in the separation of red blood cells, plasma with platelets and leucocytes. After were opened and plasma was pipetted and transferred into another sterile tube. Plasma was centrifuged again at 2000rpm for 10 minutes; as a result it was split into two parts: on the top, consisting of platelet-poor plasma (PPP) and at the bottom of the platelet button. Part of the PPP was discarded so that only 1ml remained in the tube along with the platelet button. This material was gently agitated to promote platelets resuspension and activated when added 0.3ml of calcium gluconate, resulting in PRP gel. Double centrifugation protocol was able to make platelet concentration 3 times higher in relation to the initial blood sample. The volume of calcium gluconate used for platelet activation was 0.3ml, and was sufficient to coagulate the sample. Coagulation time ranged from 8 to 20 minutes, with an average of 17.6 minutes. Therefore, time of blood centrifugation until to obtain PRP gel took only 40 minutes. It was concluded that PRP was successfully obtained by double centrifugation protocol, which is able to increase the platelet concentration in the sample compared with whole blood, allowing its use in surgical procedures. Furthermore, the preparation time is appropriate to obtain PRP in just 40 minutes, and calcium gluconate is able to promote the activation of platelets.
Article
Full-text available
Aim: The use of botanical remedies as adjunct therapies in the management of diabetes mellitus is on the increase. Anacardium occidentale has been reported in the literature to possess anti-diabetic and hypoglycemic properties. This study evaluated the effects of acute treatment of A. occidentale on blood glucose and epididymis histopathology of streptozotocin (STZ)-diabetic rats. Materials and Methods: Forty adult male Wistar rats were randomly divided into 4 experimental groups of 10 rats each. A group served as the normoglycemic control and was administered 1 ml/kg bw/day citrate buffer. Hyperglycemia was induced in 30 overnight-fasted rats with a single i.p injection of STZ (70 mg/kg bw/day). Hyperglycemia was confirmed 48 h later and thereafter allowed to stabilize for 5 days. 300 mg/kg bw/day of ethanolic extract of A. occidentale was administered orally to a group of diabetic rats ( n = 10). Insulin was also administered subcutaneously at 10 I.U/kg bw/day to another group ( n = 10). Another group served as the hyperglycemic control and received 1 ml of citrate buffer/kg bw/day. Treatment after a 5-day stabilization of hyperglycemia lasted for 17 days. In each group blood glucose and epididymal histology were assessed. Results: By the end of the experimental period, all hyperglycemic rats in the extract-treated group had become normoglycemic. Moreover, extract-treated rats showed improved epididymal morphology and luminal sperm aggregate within the duct comparable to normoglycemic and insulin-treated rats. Conclusion: We conclude that A. occidentale proved valuable in mitigating the detrimental effects of hyperglycemia on the epididymis.
Article
Full-text available
Platelet-rich blood derivatives have been widely used in different fields of medicine and stem cell-based tissue engineering. They represent natural cocktails of autologous growth factors, which could provide an alternative for recombinant protein-based approaches. Platelet-rich blood derivatives, such as platelet-rich plasma, have consistently shown to potentiate stem cell proliferation, migration, and differentiation. Here, we review the spectrum of platelet-rich blood derivatives, discuss their current applications in tissue engineering and regenerative medicine, reflect on their effect on stem cells, and highlight current translational challenges.
Article
Full-text available
ABSTRACT Streptozotocin is a permanent diabetogenic compound, produced by the gram positive soil bacterium Streptomyces achromogenes that exhibits broad spectrum of antibacterial properties.STZ induces diabetes mellitus in laboratory animals by killing insulin-producing pancreatic β- cells.Streptozotocin is a toxic glucoseanalogue that preferentially accumulate in pancreatic beta cells via the low affinity glucose transporter GLUT2.The toxic effector mechanism of STZ starts with its decomposed products and the free radicals generated, which destroy the pancreatic β- cells by alkylating DNA, impairing mitochondrial system and inhibiting O-GlcNAcase. Keywords: Streptozotocin, diabetesmellitus, GLUT2, O-GlcNAcase
Article
Objective: Chronic non-communicable diseases, such as type 2 diabetes mellitus, have become global major health problems. In the United Republic of Tanzania, previous studies showed diabetes prevalences ranging from 0.6% to 5.8% and of pre-diabetes, from 9.1% to 10.6%. The pre-diabetes screening procedure described here was a targeted screening to recruit eligible subjects for a subsequent dietary intervention in Moshi, Tanzania. Methods: The pre-diabetes screening procedure described here was used to identify subjects for a dietary intervention in Moshi, Tanzania. Main enrollment criteria for participants were fasting plasma glucose levels of 5.6- 6.9 mmol/L (100-125 mg/dL) on two days or on one day plus HbA1c in the range of 5.7-7.5% (39-58% mmol/mol), body mass index of 27-35 kg/m2, and age between 30-65 years. Results: Through pre-screening of a total of 1,256 people were examined for BMI and age; 382 people were further screened for markers of pre-diabetes. Following ADA and WHO-criteria, 51% (73%) had normal, 35% (13%) pre-diabetic, and 15% (15%) diabetic fasting plasma glucose levels. Among the individuals with hyperglycemia indicating diabetes mellitus, 60% were unaware of their condition. Applying ADA criteria for HbA1c to all people, 42% had normal, 42% had pre-diabetic, and 16% had diabetic HbA1c levels. Identified risk factors for increased fasting plasma glucose were age, waist circumference, body mass index, and a family history of diabetes mellitus. Conclusion: Although the screening sample was not representative for the study area’s population and not diagnostic, the high rates of pre-diabetic and diabetic fasting plasma glucose levels are of public health concern. The low concordance between the data for FPG and HbA1c requires further investigation, as well as the discrepancy between ADA and WHO definitions of impaired fasting glucose.
Article
Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing β-cells in the pancreas. Thereby the chemokine CXC-motif ligand 10 (CXCL10) plays an important role in the recruitment of autoaggressive lymphocytes to the islets of Langerhans. Transplantation of isolated islets as a promising therapy of T1D has been hampered by early graft rejection. Here, we investigated the influence of CXCL10 on the autoimmune destruction of islet iso-grafts using RIP-LCMV mice expressing a lymphocytic choriomeningitis virus (LCMV) protein in the β-cells. RIP-LCMV islets express CXCL10 after isolation and maintain CXCL10 production after engraftment. Thus, we isolated islets from either normal or CXCL10-deficient RIP-LCMV mice and transferred them under the kidney capsule of diabetic RIP-LCMV mice. We found that the autoimmune destruction of CXCL10-deficient islet iso-grafts was significantly reduced. The autoimmune destruction was also diminished in mice administered with an anti-CXCL10 antibody. The persistent protection from autoimmune destruction was paralleled by an increase of FoxP3-positive regulatory T-cells within the cellular infiltrates around the islet iso-grafts. Consequently, CXCL10 might influence the cellular composition locally in the islet graft, thereby playing a role in the autoimmune destruction. CXCL10 might therefore constitute a potential therapeutic target to prolong islet graft survival.